Astrazeneca Plc Stock Technical Analysis
| AZN Stock | USD 92.77 0.18 0.19% |
As of the 31st of January, AstraZeneca PLC shows the Downside Deviation of 1.53, mean deviation of 1.08, and Risk Adjusted Performance of 0.0897. AstraZeneca PLC technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
AstraZeneca PLC Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as AstraZeneca, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to AstraZenecaAstraZeneca | Build AI portfolio with AstraZeneca Stock |
AstraZeneca PLC Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 101.78 | Strong Buy | 12 | Odds |
Most AstraZeneca analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand AstraZeneca stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of AstraZeneca PLC, talking to its executives and customers, or listening to AstraZeneca conference calls.
Will Pharmaceuticals sector continue expanding? Could AstraZeneca diversify its offerings? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AstraZeneca PLC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.78 | Dividend Share 3.13 | Earnings Share 3.01 | Revenue Per Share | Quarterly Revenue Growth 0.12 |
The market value of AstraZeneca PLC is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that AstraZeneca PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AstraZeneca PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, AstraZeneca PLC's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
AstraZeneca PLC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AstraZeneca PLC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AstraZeneca PLC.
| 11/02/2025 |
| 01/31/2026 |
If you would invest 0.00 in AstraZeneca PLC on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding AstraZeneca PLC or generate 0.0% return on investment in AstraZeneca PLC over 90 days. AstraZeneca PLC is related to or competes with Novartis, GlaxoSmithKline PLC, Roche Holding, Bristol Myers, Sanofi ADR, Merck, and Gilead Sciences. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercializatio... More
AstraZeneca PLC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AstraZeneca PLC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AstraZeneca PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.53 | |||
| Information Ratio | 0.0748 | |||
| Maximum Drawdown | 8.81 | |||
| Value At Risk | (2.37) | |||
| Potential Upside | 2.62 |
AstraZeneca PLC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AstraZeneca PLC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AstraZeneca PLC's standard deviation. In reality, there are many statistical measures that can use AstraZeneca PLC historical prices to predict the future AstraZeneca PLC's volatility.| Risk Adjusted Performance | 0.0897 | |||
| Jensen Alpha | 0.1348 | |||
| Total Risk Alpha | 0.0574 | |||
| Sortino Ratio | 0.0719 | |||
| Treynor Ratio | 0.3141 |
AstraZeneca PLC January 31, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0897 | |||
| Market Risk Adjusted Performance | 0.3241 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 1.31 | |||
| Downside Deviation | 1.53 | |||
| Coefficient Of Variation | 858.04 | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.16 | |||
| Information Ratio | 0.0748 | |||
| Jensen Alpha | 0.1348 | |||
| Total Risk Alpha | 0.0574 | |||
| Sortino Ratio | 0.0719 | |||
| Treynor Ratio | 0.3141 | |||
| Maximum Drawdown | 8.81 | |||
| Value At Risk | (2.37) | |||
| Potential Upside | 2.62 | |||
| Downside Variance | 2.33 | |||
| Semi Variance | 1.72 | |||
| Expected Short fall | (1.10) | |||
| Skewness | (0.17) | |||
| Kurtosis | 1.57 |
AstraZeneca PLC Backtested Returns
AstraZeneca PLC appears to be very steady, given 3 months investment horizon. AstraZeneca PLC secures Sharpe Ratio (or Efficiency) of 0.15, which signifies that the company had a 0.15 % return per unit of risk over the last 3 months. We have found thirty technical indicators for AstraZeneca PLC, which you can use to evaluate the volatility of the firm. Please makes use of AstraZeneca PLC's Downside Deviation of 1.53, risk adjusted performance of 0.0897, and Mean Deviation of 1.08 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, AstraZeneca PLC holds a performance score of 11. The firm shows a Beta (market volatility) of 0.51, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, AstraZeneca PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding AstraZeneca PLC is expected to be smaller as well. Please check AstraZeneca PLC's skewness, and the relationship between the value at risk and day median price , to make a quick decision on whether AstraZeneca PLC's price patterns will revert.
Auto-correlation | 0.57 |
Modest predictability
AstraZeneca PLC has modest predictability. Overlapping area represents the amount of predictability between AstraZeneca PLC time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AstraZeneca PLC price movement. The serial correlation of 0.57 indicates that roughly 57.0% of current AstraZeneca PLC price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.57 | |
| Spearman Rank Test | 0.51 | |
| Residual Average | 0.0 | |
| Price Variance | 2.74 |
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
AstraZeneca PLC Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of AstraZeneca PLC volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About AstraZeneca PLC Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of AstraZeneca PLC on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of AstraZeneca PLC based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on AstraZeneca PLC price pattern first instead of the macroeconomic environment surrounding AstraZeneca PLC. By analyzing AstraZeneca PLC's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of AstraZeneca PLC's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to AstraZeneca PLC specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.0228 | 0.0205 | 0.0221 | Price To Sales Ratio | 3.83 | 4.41 | 4.19 |
AstraZeneca PLC January 31, 2026 Technical Indicators
Most technical analysis of AstraZeneca help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for AstraZeneca from various momentum indicators to cycle indicators. When you analyze AstraZeneca charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0897 | |||
| Market Risk Adjusted Performance | 0.3241 | |||
| Mean Deviation | 1.08 | |||
| Semi Deviation | 1.31 | |||
| Downside Deviation | 1.53 | |||
| Coefficient Of Variation | 858.04 | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.16 | |||
| Information Ratio | 0.0748 | |||
| Jensen Alpha | 0.1348 | |||
| Total Risk Alpha | 0.0574 | |||
| Sortino Ratio | 0.0719 | |||
| Treynor Ratio | 0.3141 | |||
| Maximum Drawdown | 8.81 | |||
| Value At Risk | (2.37) | |||
| Potential Upside | 2.62 | |||
| Downside Variance | 2.33 | |||
| Semi Variance | 1.72 | |||
| Expected Short fall | (1.10) | |||
| Skewness | (0.17) | |||
| Kurtosis | 1.57 |
AstraZeneca PLC January 31, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as AstraZeneca stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | 0.19 | ||
| Rate Of Daily Change | 1.00 | ||
| Day Median Price | 93.05 | ||
| Day Typical Price | 92.96 | ||
| Price Action Indicator | (0.19) | ||
| Market Facilitation Index | 0.96 |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in AstraZeneca Stock, please use our How to Invest in AstraZeneca PLC guide.You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Will Pharmaceuticals sector continue expanding? Could AstraZeneca diversify its offerings? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every AstraZeneca PLC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.78 | Dividend Share 3.13 | Earnings Share 3.01 | Revenue Per Share | Quarterly Revenue Growth 0.12 |
The market value of AstraZeneca PLC is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that AstraZeneca PLC's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether AstraZeneca PLC represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, AstraZeneca PLC's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.